Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1978 Aug;92(2):473–490.

Dose-dependent inhibition of experimental arterial thrombosis by carbenicillin and ticarcillin.

B T Lyman, G J Johnson, J G White
PMCID: PMC2018296  PMID: 677271

Abstract

An experimental model of canine arterial thrombosis was used to study by prophylactic antithrombotic effectiveness of carbenicillin and ticarcillin, two semisynthetic penicillins which have been shown to inhibit platelet function in vivo. Isolated peripheral arterial segments were injected with pronase and biopsied at 24 hours. In untreated dogs, 89% of injected segments totally occluded with thrombus. Prophylactic treatment for 3 to 7 days with carbenicillin or ticarcillin in low doses (250 mg/kg/day) or high doses 750 mg/kg/day) significantly decreased the incidence of total occlusion to 53% and 6%, respectively. The dose-dependent inhibition of arterial thrombosis correlated with dose-dependent inhibition of platelet function. Prophylactic treatment with aspirin in low doses (650 mg/day) or high doses (2600 mg/day) did not significantly decrease the incidence of total occlusion in this model. Carbenicillin and ticarcillin are effective experimental antithrombotic agents.

Full text

PDF
473

Images in this article

490Figure 7
on p.490
490Figure 8
on p.490
487Figure 1
on p.487
487Figure 2
on p.487
488Figure 3
on p.488
488Figure 4
on p.488
489Figure 5
on p.489
489Figure 6
on p.489

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrassy K., Ritz E., Schoeffner W., Hahn G., Walter K. The influence of acetylsalicylic acid on platelet adhesiveness and thrombotic fistula complications in hemodialysed patients. Klin Wochenschr. 1971 Feb;49(3):166–167. doi: 10.1007/BF01496814. [DOI] [PubMed] [Google Scholar]
  2. BORN G. V., CROSS M. J. THE AGGREGATION OF BLOOD PLATELETS. J Physiol. 1963 Aug;168:178–195. doi: 10.1113/jphysiol.1963.sp007185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baumgartner H. R. The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi. Microvasc Res. 1973 Mar;5(2):167–179. doi: 10.1016/0026-2862(73)90069-1. [DOI] [PubMed] [Google Scholar]
  4. Bick R. L., Adams T., Schmalhorst W. R. Bleeding times, platelet adhesion, and aspirin. Am J Clin Pathol. 1976 Jan;65(1):69–72. doi: 10.1093/ajcp/65.1.69. [DOI] [PubMed] [Google Scholar]
  5. Bodey G. P., Rodriguez V., Stewart D. Clinical pharmacological studies of carbenicillin. Am J Med Sci. 1969 Mar;257(3):185–190. doi: 10.1097/00000441-196903000-00005. [DOI] [PubMed] [Google Scholar]
  6. Bowie E. J., Owen C. A., Jr, Thompson J. H., Didisheim P. Platelet adhesiveness in von Willebrand's disease. Am J Clin Pathol. 1969 Jul;52(1):69–77. doi: 10.1093/ajcp/52.1.69. [DOI] [PubMed] [Google Scholar]
  7. Brown C. H., 3rd, Natelson E. A., Bradshaw M. W., Alfrey C P., Jr, Williams T. W., Jr Study of the effects of ticarcillin on blood coagulation and platelet function. Antimicrob Agents Chemother. 1975 May;7(5):652–657. doi: 10.1128/aac.7.5.652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Brown C. H., 3rd, Natelson E. A., Bradshaw W., Williams T. W., Jr, Alfrey C. P., Jr The hemostatic defect produced by carbenicillin. N Engl J Med. 1974 Aug 8;291(6):265–270. doi: 10.1056/NEJM197408082910601. [DOI] [PubMed] [Google Scholar]
  9. Browse N. L., Hall J. H. Effect of dipyridamole on the incidence of clinically detectable deep-vein thrombosis. Lancet. 1969 Oct 4;2(7623):718–720. doi: 10.1016/s0140-6736(69)90429-2. [DOI] [PubMed] [Google Scholar]
  10. Bull B. S., Schneiderman M. A., Brecher G. Platelet counts with the Coulter counter. Am J Clin Pathol. 1965 Dec;44(6):678–688. doi: 10.1093/ajcp/44.6.678. [DOI] [PubMed] [Google Scholar]
  11. Cazenave J-P, Guccione M. A., Packham M. A., Mustard J. F. Effects of cephalothin and penicillin G on platelet function in vitro. Br J Haematol. 1977 Jan;35(1):135–152. doi: 10.1111/j.1365-2141.1977.tb00569.x. [DOI] [PubMed] [Google Scholar]
  12. Cazenave J. P., Packham M. A., Guccione M. A., Mustard J. F. Effects of penicillin G on platelet aggregation, release, and adherence to collagen. Proc Soc Exp Biol Med. 1973 Jan;142(1):159–166. doi: 10.3181/00379727-142-36980. [DOI] [PubMed] [Google Scholar]
  13. Cazenave J. P., Packham M. A., Mustard J. F. Adherence of platelets to a collagen-coated surface: development of a quantitative method. J Lab Clin Med. 1973 Dec;82(6):978–990. [PubMed] [Google Scholar]
  14. Cucuianu M. P., Nishizawa E. E., Mustard J. F. Effect of pyrimido-pyrimidine compounds on platelet function. J Lab Clin Med. 1971 Jun;77(6):958–974. [PubMed] [Google Scholar]
  15. DAVIS N. C., SMITH E. L. Assay of proteolytic enzymes. Methods Biochem Anal. 1955;2:215–257. doi: 10.1002/9780470110188.ch8. [DOI] [PubMed] [Google Scholar]
  16. DEATON H. L., ANLYAN W. G. A study of experimental methods for producing thrombosis in small arteries. Surg Gynecol Obstet. 1960 Aug;111:131–134. [PubMed] [Google Scholar]
  17. Didisheim P. Animal models useful in the study of thrombosis and antithrombotic agents. Prog Hemost Thromb. 1972;1:165–197. [PubMed] [Google Scholar]
  18. Didisheim P. Inhibition by dipyridamole of arterial thrombosis in rats. Thromb Diath Haemorrh. 1968 Nov 15;20(1):257–266. [PubMed] [Google Scholar]
  19. Dyken M. L., Kolar O. J., Jones F. H. Differences in the occurrence of carotid transient ischemic attacks associated with antiplatelet aggregation therapy. Stroke. 1973 Sep-Oct;4(5):732–736. doi: 10.1161/01.str.4.5.732. [DOI] [PubMed] [Google Scholar]
  20. Elwood P. C., Cochrane A. L., Burr M. L., Sweetnam P. M., Williams G., Welsby E., Hughes S. J., Renton R. A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. Br Med J. 1974 Mar 9;1(5905):436–440. doi: 10.1136/bmj.1.5905.436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Emmons P. R., Harrison M. J., Honour A. J., Mitchell J. R. Effect of a pyrimidopyrimidine derivative on thrombus formation in the rabbit. Nature. 1965 Oct 16;208(5007):255–257. doi: 10.1038/208255a0. [DOI] [PubMed] [Google Scholar]
  22. Emmons P. R., Harrison M. J., Honour A. J., Mitchell J. R. Effect of dipyridamole on human platelet behaviour. Lancet. 1965 Sep 25;2(7413):603–606. doi: 10.1016/s0140-6736(65)90515-5. [DOI] [PubMed] [Google Scholar]
  23. Evans G. Effect of drugs that suppress platelet surface interaction on incidence of amaurosis fugax and transient cerebral ishcemia. Surg Forum. 1972;23(0):239–241. [PubMed] [Google Scholar]
  24. Genton E., Gent M., Hirsh J., Harker L. A. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts). N Engl J Med. 1975 Dec 18;293(25):1296–1300. doi: 10.1056/NEJM197512182932506. [DOI] [PubMed] [Google Scholar]
  25. Gray G. R., Wilson P. A., Douglas A. S. The effect on dipyridamole on platelet aggregation and adhesiveness. Scott Med J. 1968 Dec;13(12):409–415. doi: 10.1177/003693306801301202. [DOI] [PubMed] [Google Scholar]
  26. Harker L. A., Hirsh J., Gent M., Genton E. Critical evaluation of platelet-inhibiting drugs in thrombotic disease. Prog Hematol. 1975;9:229–254. [PubMed] [Google Scholar]
  27. Harker L. A., Slichter S. J. Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. N Engl J Med. 1970 Dec 10;283(24):1302–1305. doi: 10.1056/NEJM197012102832402. [DOI] [PubMed] [Google Scholar]
  28. Johnson G. J., Rao G. H., White J. G. Platelet dysfunction induced by parenteral carbenicillin and ticarcillin. Studies of the dose-response relationship and mechanism of action in dogs. Am J Pathol. 1978 Apr;91(1):85–106. [PMC free article] [PubMed] [Google Scholar]
  29. Kaegi A., Pineo G. F., Shimizu A., Trivedi H., Hirsh J., Gent M. Arteriovenous-shunt thrombosis. Prevention by sulfinpyrazone. N Engl J Med. 1974 Feb 7;290(6):304–306. doi: 10.1056/NEJM197402072900604. [DOI] [PubMed] [Google Scholar]
  30. Kaegi A., Pineo G. F., Shimizu A., Trivedi H., Hirsh J., Gent M. The role of sulfinpyrazone in the prevention of arterio-venous shunt thrombosis. Circulation. 1975 Sep;52(3):497–499. doi: 10.1161/01.cir.52.3.497. [DOI] [PubMed] [Google Scholar]
  31. Klastersky J., Henri A., Daneau D. Ticarcillin, a new semisynthetic penicillin active on Pseudomonas aeruginosa: in vitro activity and blood levels in man. J Clin Pharmacol. 1974 Apr;14(4):172–175. doi: 10.1002/j.1552-4604.1974.tb01394.x. [DOI] [PubMed] [Google Scholar]
  32. Lynn B. Administration of carbenicillin and ticarcillin--pharmaceutical aspects. Eur J Cancer. 1973 Jun;9(6):425–433. doi: 10.1016/0014-2964(73)90107-2. [DOI] [PubMed] [Google Scholar]
  33. Mason R. G., Wolf R. H., Zucker W. H., Shinoda B. A. Dynamics of thrombus formation on an artificial surface in vivo. Effects of antithrombotic agents. Am J Pathol. 1976 Mar;82(3):445–456. [PMC free article] [PubMed] [Google Scholar]
  34. Mayer J. E., Jr, Hammond G. L. Dipyridamole and aspirin tested against an experimental model of thrombosis. Ann Surg. 1973 Jul;178(1):108–112. doi: 10.1097/00000658-197307000-00021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Mayne E. E., Bridges J. M., Weaver J. A. The effect of dipyridamole on increased levels of platelet adhesiveness. Report of a controlled clinical trial. J Atheroscler Res. 1969 May-Jun;9(3):335–338. doi: 10.1016/s0368-1319(69)80027-x. [DOI] [PubMed] [Google Scholar]
  36. McClure P. D., Casserly J. G., Monsier C., Crozier D. Carbenicillin-induced bleeding disorder. Lancet. 1970 Dec 19;2(7686):1307–1308. doi: 10.1016/s0140-6736(70)92264-6. [DOI] [PubMed] [Google Scholar]
  37. Mustard J. F., Packham M. A. Factors influencing platelet function: adhesion, release, and aggregation. Pharmacol Rev. 1970 Jun;22(2):97–187. [PubMed] [Google Scholar]
  38. Neu H. C., Garvey G. J. Comparative in vitro activity and clinical pharmacology of ticarcillin and carbenicillin. Antimicrob Agents Chemother. 1975 Oct;8(4):457–462. doi: 10.1128/aac.8.4.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Packham M. A., Mustard J. F. Clinical pharmacology of platelets. Blood. 1977 Oct;50(4):555–573. [PubMed] [Google Scholar]
  40. SMYTHE H. A., OGRYZLO M. A., MURPHY E. A., MUSTARD J. F. THE EFFECT OF SULFINPYRAZONE (ANTURAN) ON PLATELET ECONOMY AND BLOOD COAGULATION IN MAN. Can Med Assoc J. 1965 Apr 10;92:818–821. [PMC free article] [PubMed] [Google Scholar]
  41. Steele P. P., Weily H. S., Genton E. Platelet survival and adhesiveness in recurrent venous thrombosis. N Engl J Med. 1973 May 31;288(22):1148–1152. doi: 10.1056/NEJM197305312882203. [DOI] [PubMed] [Google Scholar]
  42. Sullivan J. M., Harken D. E., Gorlin R. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report. N Engl J Med. 1968 Sep 12;279(11):576–580. doi: 10.1056/NEJM196809122791104. [DOI] [PubMed] [Google Scholar]
  43. Sullivan J. M., Kagnoff M. F., Gorlin R. Reduction of platelet adhesiveness in patients with coronary artery disease. Am J Med Sci. 1968 May;255:292–295. doi: 10.1097/00000441-196805000-00004. [DOI] [PubMed] [Google Scholar]
  44. Waisbren B. A., Evani S. V., Ziebert A. P. Carbenicillin and bleeding. JAMA. 1971 Aug 30;217(9):1243–1243. [PubMed] [Google Scholar]
  45. Weily H. S., Genton E. Altered platelet function in patients with prosthetic mitral valves. Effects of sulfinpyrazone therapy. Circulation. 1970 Nov;42(5):967–972. doi: 10.1161/01.cir.42.5.967. [DOI] [PubMed] [Google Scholar]
  46. Weiss H. J. Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis. Am Heart J. 1976 Jul;92(1):86–102. doi: 10.1016/s0002-8703(76)80408-5. [DOI] [PubMed] [Google Scholar]
  47. Weiss H. J. Aspirin ingestion compared with bleeding disorders--search for a useful platelet antiaggregant. Blood. 1970 Mar;35(3):333–340. [PubMed] [Google Scholar]
  48. Weiss H. J., Tschopp T. B., Baumgartner H. R. Impaired interaction (adhesion-aggregation) of platelets with the subendothelium in storage-pool disease and after aspirin ingestion. A comparison with von Willebrand's disease. N Engl J Med. 1975 Sep 25;293(13):619–623. doi: 10.1056/NEJM197509252931301. [DOI] [PubMed] [Google Scholar]
  49. Zucker M. B., Peterson J. Effect of acetylsalicylic acid, other nonsteroidal anti-inflammatory agents, and dipyridamole on human blood platelets. J Lab Clin Med. 1970 Jul;76(1):66–75. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES